Pharmaceuticals This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 35.

EUR 3 million for new Humboldt-Bayer research fellowships
Financing for 10 post-doctoral fellowships a year through 2018 / Focus on the life sciences, chemistry and pharmacy
Source: Bayer Company News - January 25, 2013 Category: Pharmaceuticals Source Type: news

Biocon eyes Rs 100 cr from psoriasis drug
The product would be manufactured and formulated as an infusion drug at Biocon's biopharma manufacturing facility at Biocon Park, Bangalore.
Source: The Economic Times Healthcare and Biotech News - January 25, 2013 Category: Pharmaceuticals Source Type: news

Biocon to launch new drug in July-September quarter
Biocon expects sales of Rs 1 billion ($18.6 million) from the drug over four years, Kiran Mazumdar-Shaw, chairman, Biocon said in a conference call.
Source: The Economic Times Healthcare and Biotech News - January 25, 2013 Category: Pharmaceuticals Source Type: news

Pfizer eyes buyout of Strides Arcolab unit Agila
Pfizer is among the companies weighing a purchase of the injectable-medicines unit of Indian drug supplier Strides Arcolab.
Source: The Economic Times Healthcare and Biotech News - January 25, 2013 Category: Pharmaceuticals Source Type: news

OXYCONTIN (Oxycodone Hydrochloride) Tablet, Film Coated, Extended Release [Purdue Pharma LP]
Updated Date: Jan 25, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 25, 2013 Category: Drugs & Pharmacology Source Type: news

Important Cold Weather Safety and Tips
With the onset of frigid temperatures in the Northeast and Midwest over the past week, it is important to remember to dress warmly--most importantly to dress in layers with wool sweaters and fleece, and to keep your head, ears, nose and face covered with a warm headgear and facemask combination. Body heat is easily lost through the head and scalp.
Source: Forbes.com Healthcare News - January 24, 2013 Category: Pharmaceuticals Authors: Robert Glatter, MD Source Type: news

Can Your Smartphone Spread The Flu?
As the flu season rages on, most of us try to practice good hygiene by washing our hands, avoiding close contact with others who are ill, and getting a flu shot. But another potential vector for the spread of the flu that has recently been discussed in the media may be your smartphone.
Source: Forbes.com Healthcare News - January 24, 2013 Category: Pharmaceuticals Authors: Robert Glatter, MD Source Type: news

Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
Fuisz Pharma LLC announced today that it has received a notice of allowance from the United States Patent and Trademark Office in connection with its utility patent application entitled "Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit" (US 20120141545).
Source: Pharmaceutical Online News - January 24, 2013 Category: Pharmaceuticals Source Type: news

Glocal Healthcare Systems: IAS officer-turned-entrepreneur plans to open 50 more hospitals
Former Indian Administrative Services officer Sabahat S Azim’s biggest challenge when he launched affordable healthcare chain Glocal Healthcare Systems was to prove that he could make the hospitals profitable.
Source: The Economic Times Healthcare and Biotech News - January 24, 2013 Category: Pharmaceuticals Source Type: news

Biodel Reports Positive Top-Line Results From Clinical Study Of Ultra-Rapid-Acting Insulin Analog Candidates
Biodel Inc. (Nasdaq:BIOD) today announced positive top-line results from a Phase 1 clinical trial of two ultra-rapid-acting insulin analog-based formulations, BIOD-238 and BIOD-250, conducted to evaluate the pharmacokinetic and injection site toleration profiles relative to Humalog®, a rapid-acting insulin analog.
Source: Pharmaceutical Online News - January 24, 2013 Category: Pharmaceuticals Source Type: news

Southern National Bancorp of Virginia, Inc. Reports Earnings of $6.6 Million for 2012 Compared to $4.4 Million in 2011; Declares Fourth Consecutive Regular Dividend
MCLEAN, Va., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Southern National Bancorp of Virginia, Inc. (Nasdaq:SONA) ("Southern National") announced today that net income for the year ended December 31, 2012 was $6.6 million compared to $4.4 million for the year ended December 31, 2011. In addition, Southern National declared a regular quarterly dividend of $.05 per share payable on February 22, 2013 to shareholders of record on February 11, 2013. Southern National had previously paid regular dividends for the first three quarters of the year in the total amount of $.08 per share. In addition, a special dividend of $0.15 was declared ...
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) --
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

BG Medicine, Inc. Enters Into $12 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
WALTHAM, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that it has entered into a common stock purchase agreement with Aspire Capital Fund, LLC. Aspire has committed to purchase up to $12 million of BG Medicine's common stock from time to time as directed by BG Medicine over the next two years at prices based on prevailing market prices over a period preceding each sale after the SEC declares a registration statement effective relating to the transaction.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Straightforward Bullying Prevention Advice for Parents, Children and Schools
SEATTLE, Jan. 24, 2013 (GLOBE NEWSWIRE) -- We hear a lot about bullying these days: its prevalence, its causes, its effects. Less frequently do we hear about solutions to bullying: tangible, practical things we can do to keep our children safe.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Federal Home Loan Bank of Indianapolis Announces Repurchase of Excess Stock
INDIANAPOLIS, Jan. 24, 2013 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of Indianapolis ("Bank") announced today that it will repurchase up to $250,000,000 in par value of excess stock from shareholders that are former members (or their successors-in-interest) with excess stock (provided that no fractional shares will be repurchased). This repurchase is in accordance with Section VI.C of the Bank's Capital Plan dated September 19, 2002 (as amended) and is being undertaken for general capital management purposes. The excess stock that is subject to the repurchase is currently subject to mandatory redemption requests and ...
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Mid-Con Energy Partners, LP Announces Increased Quarterly Cash Distribution and Schedules Fourth Quarter 2012 Earnings Release and Conference Call
DALLAS, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Mid-Con Energy Partners, LP (Nasdaq:MCEP) ("Mid-Con Energy" or the "Partnership") announced today that the board of directors of its general partner declared an increase in the quarterly cash distribution rate to $0.495 per unit for the quarter ended December 31, 2012. This represents an approximate 2% sequential increase over the $0.485 per unit rate declared for the quarter ended September 30, 2012, and results in an annualized distribution of $1.98 per unit.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

First Financial Holdings, Inc. Announces Fourth Quarter Earnings and Declares Cash Dividend
CHARLESTON, S.C., Jan. 24, 2013 (GLOBE NEWSWIRE) -- First Financial Holdings, Inc. ("First Financial") (Nasdaq:FFCH), the holding company for First Federal Bank ("First Federal"), announced today net income available to common shareholders of $6.8 million for the three months ended December 31, 2012, compared with $5.7 million for the three months ended September 30, 2012 and $14.6 million for the three months ended December 31, 2011. Diluted net income per common share was $0.41 for the quarter ended December 31, 2012, compared with $0.34 for the prior quarter and $0.88 for the same quarter last year. The quarter ended De...
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Hancock Reports Fourth Quarter 2012 Financial Results
GULFPORT, Miss., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Hancock Holding Company (Nasdaq:HBHC) today announced financial results for the fourth quarter of 2012. Net income for the fourth quarter of 2012 was $47.0 million, or $.54 per diluted common share, compared to $47.0 million, or $.55, in the third quarter of 2012. Net income was $19.0 million, or $.22, in the fourth quarter of 2011. Pre-tax earnings for the third and fourth quarters of 2012 included no merger-related costs. The fourth quarter of 2011 included pre-tax merger-related costs of $40.2 million.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Marlin Business Services Corp. Announces Its Fourth Quarter and Year-End Conference Call and Webcast
MOUNT LAUREL, N.J., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Marlin Business Services Corp. (Nasdaq:MRLN) conference call details are as follows:
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

MBT Financial Corp. Announces Fourth Quarter and Full Year 2012 Profit
MONROE, Mich., Jan. 24, 2013 (GLOBE NEWSWIRE) -- MBT Financial Corp., (Nasdaq:MBTF), the parent company of Monroe Bank & Trust, reported a preliminary net profit of $6,118,000, or $0.36 per share (basic and diluted), in the fourth quarter of 2012, compared to the profit of $431,000, or $0.02 per share (basic and diluted) in the fourth quarter of 2011. The year to date profit is $8,976,000, or $0.52 per share (basic and diluted), compared to a loss of $3,762,000, or $0.22 per share in 2011. Included in the positive results for the quarter is a $5 million reduction in the Company's valuation allowance against its deferred ta...
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

CORRECTION -- Bryn Mawr Bank Corporation Reports Record Earnings for 2012, Boosts Wealth Assets by 38.4% to $6.7 Billion
BRYN MAWR, Pa., Jan. 24, 2013 (GLOBE NEWSWIRE) -- In a press release issued today by Bryn Mawr Bank Corporation (Nasdaq:BMTC) with the same headline, please note that the wealth asset value on the headline should be $6.7 billion, not $6.4 billion as originally stated. All other data was correct.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Northfield Bancorp, Inc. Announces Closing of Stock Offering and Completion of Conversion Transaction
WOODBRIDGE, N.J., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Northfield Bancorp, Inc., a Delaware corporation (the "Company") (Nasdaq:NFBK), announced today that it has completed the "second step" conversion of Northfield Bancorp, MHC (the "MHC") and the Company's related stock offering, effective as of the close of business today. As a result of the closing of the conversion and offering, the Company is now the holding company for Northfield Bank (the "Bank"). The MHC and the Bank's former mid-tier holding company, also named Northfield Bancorp, Inc., have ceased to exist. The results of the stock offering were previously reported...
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Heritage Commerce Corp Reports Net Income Available to Shareholders of $2.7 Million for the Fourth Quarter of 2012 and $8.7 Million for 2012
SAN JOSE, Calif., Jan. 24, 2013 (GLOBE NEWSWIRE) --
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Rosetta Resources Inc. Announces Record Production and Proved Reserves for 2012 and Reduced Eagle Ford Well Costs
HOUSTON, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Rosetta Resources Inc. (Nasdaq:ROSE) ("Rosetta" or the "Company") today reported preliminary operational results for 2012 that include double-digit growth in production and proved reserves and significantly reduced well costs. The Company plans to report final 2012 results on Monday, February 25, 2013.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Waterford Development Corporation in Cooperation With AmeriBid LLC to Offer at Auction the Silver Mountain Resort in Kellogg, Idaho
KELLOGG, Idaho, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Waterford Development Corporation of Needham, Massachusetts, (
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

BJ's Restaurants, Inc. Donates $534,000 to the Cystic Fibrosis Foundation From 2012 Fundraising Activities
HUNTINGTON BEACH, Calif., Jan. 24, 2013 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (Nasdaq:BJRI), a long time supporter of the Cystic Fibrosis Foundation, announced today that the Company, in partnership with the BJ's Restaurants Foundation, raised a grand total of $534,000 for the Cystic Fibrosis Foundation during 2012 through its new restaurant grand-opening charity events, other fundraising campaigns and its Cookies for Kids program.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

First Horizon National Corp. Announces Pricing of $100 Million Public Offering of Depositary Shares Representing Series A Preferred Stock
MEMPHIS, Tenn., Jan. 24, 2013 (GLOBE NEWSWIRE) -- First Horizon National Corporation (NYSE:FHN) announced today the pricing of an underwritten public offering of $100 million aggregate liquidation preference amount of depositary shares, each representing 1/4,000th interest in a share of its Non-Cumulative Perpetual Preferred Stock, Series A, at a fixed annual dividend rate of 6.20 percent. First Horizon intends to use the net proceeds of this offering for general corporate purposes.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Palomar Medical Technologies to Host Fourth Quarter and Fiscal Year 2012 Financial Results Conference Call and Webcast on February 7, 2013 at 11:30 AM Eastern Time
BURLINGTON, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Palomar Medical Technologies, Inc. (Nasdaq:PMTI), a global leader in laser and other light-based systems for aesthetic treatments, will hold its quarterly conference call of its 2012 fourth quarter and fiscal year financial results on Thursday, February 7, 2013 at 11:30 AM Eastern Time. If you would like to participate, please call (877) 881-2595 at 11:20 AM Eastern Time on that day.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Martin Midstream Partners Announces Quarterly Cash Distribution and Release Date of Fourth Quarter and Fiscal Year 2012 Results
KILGORE, Texas, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Martin Midstream Partners L.P. (Nasdaq:MMLP) announced today it has declared a quarterly cash distribution of $0.77 per unit for the quarter ended December 31, 2012 and plans to publicly release its financial results for the fourth quarter and fiscal year ended December 31, 2012 after the market closes on Wednesday, February 27, 2013.
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

Northfield Bancorp, Inc. Announces Fourth Quarter 2012 Results
Source: Medical News (via PRIMEZONE) - January 24, 2013 Category: Pharmaceuticals Source Type: news

DePuy ASR Hip Recall: Johnson & Johnson Learned of Problems Two...
Bernstein Liebhard LLP is currently investigating DePuy ASR Hip lawsuits on behalf of individuals who suffered metallosis, early hip implant failure and other complications due to Johnson &...(PRWeb January 23, 2013)Read the full story at http://www.prweb.com/releases/depuy-asr-hip-recall/depuy-asr-hip-lawsuit/prweb10356290.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

DePuy ASR Hip Lawsuit Trial: Johnson & Johnson Analysis Showed...
Bernstein Liebhard LLP is actively filing claims on behalf of individuals affected by the August 2010 DePuy ASR hip recall.(PRWeb January 23, 2013)Read the full story at http://www.prweb.com/releases/depuy-asr-hip-lawsuits/depuy-asr-hip-recall/prweb10353396.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

United States Postal Service Selects PMSI as its Pharmacy Benefit...
One of the largest workers' compensation specialty services providers, PMSI, has been selected to provide workers' compensation pharmacy services for the Postal Service.(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10358060.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Nothing Stuffy About Contac Brand Redesign
Contac cold and flu medicine is hitting shelves with a new look for the New Year(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10356319.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

TC3 Imaging Core Lab Attains ISO 9001:2008 Certification
Results of audit prove TC3’s uncompromising commitment to quality(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10354582.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Adlib Appoints Industry Veteran John Hanrahan as Principal, Life...
Former EMC Documentum, Global Life Sciences Advisor for Pharmaceutical, Bio-Technology and Medical Devices Industries, John Hanrahan joins Adlib as Principal of Life Sciences. Adlib helps the life...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10354409.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

PhaseRx Announces Technology Evaluation Agreement with Monsanto
Monsanto to evaluate PhaseRx's SMARTT Polymer Technology® for potential agricultural applications.(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10353976.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Farewell to TQT studies, new webinar hosted by Xtalks
Xtalks presents an exciting live webinar on Thursday, February 7, 2013 at 11:00am EST on TQT studies. Join keynote speakers Dr. Jay Mason, Chief Medical Officer at Spaulding Clinical Research; Dr....(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10353974.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

CBPartners Releases New Thought Piece on HTA in the Emerging Markets
Developed by Rachel Beckerman, PhD, Principal of Value Demonstration at CBPartners, the thought piece aims to elucidate the status of HTA adoption and implementation in the emerging markets by...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10353750.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Bringing New Cell Therapies to Market Requires Top-Notch Logistics and...
The 2013 Annual Phalicitate Gene & Cell Therapy Forum to Include Presentations by Fisher BioServices’ Cold-Chain Logistics Experts(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/FisherBioServices/Cell-Therapy/prweb10352838.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces...
Diet Doc introduced new electrolyte replacement supplements to ensure that dieters on a low calorie diet plan do not fall victim to electrolyte imbalance.(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/electrolyte-imbalance/weight-loss/prweb10351613.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

DynaCon® Conveyors Help to Increase Productivity of American...
Labor usage efficiencies are increased with indexing conveyor system from Dynamic Conveyor.(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/conveyor/boxfilling/prweb10350315.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Idem Translations Achieves ISO 13485:2003 Certification
Idem Translations, Inc., a full-service provider of translation and localization services, has achieved ISO 13485:2003 certification, which is specific quality certification for the translation of...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/idemtranslations/iso13485/prweb10346208.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Wohl Associates Expands Their Inventory of Colloid Mills with the...
Wohl Associates widens their inventory of colloid mills with the Greerco W500H stainless steel horizontal colloid mill for sale. They offer 43 different colloid mills and homogenizers on their site to...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/colloid-mills/pre-owned-colloid-mills/prweb10340431.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Wright Conserve Hip Replacement Lawsuit Conference Scheduled for...
Bernstein Liebhard LLP Now Investigating Wright Hip Implant Lawsuits Involving Wright Conserve Hip Replacements, Wright Profemur Hip Implants.(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/Wright-Conserve-Hip/Wright-Profemur-Hip/prweb10359000.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

More Stryker Hip Recall Lawsuits Expected, As Cost of Recall Grows,...
Bernstein Liebhard LLP is currently investigating Stryker Hip recall lawsuits on behalf of individuals affected by the Stryker Rejuvenate and ABG II Modular-Neck Hip Stem recall.(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/stryker-hip-recall/stryker-rejuvenate-recall/prweb10358549.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Gammagard Problematic for Success in Mild-to-Moderate Alzheimer’s:...
On January 22nd 2013, the Financial Times published that Phase III Gammagard clinical trial has been met with reservation from experts, who cited the mild-to-moderate patient population as problematic...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10353252.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

The FSH Society Answers Questions About the New Gene for FSH Muscular...
Fueled by funding from the FSH Society, an international research team has discovered the genes that cause facioscapulohumeral muscular dystrophy (FSHD), a devastating muscle-wasting disease that...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10348916.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills...
The US Drug Watchdog says, "If you, a daughter, or a friend were using birth control pills called Yaz, Yasmin, or their generic version Ocella, and severe side conditions occurred, such a...(PRWeb January 24, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10332531.htm
Source: PRWeb: Medical Pharmaceuticals - January 24, 2013 Category: Pharmaceuticals Source Type: news

Full disclosure: GSK's pledge to open clinical trial data
Just a few months after GlaxoSmithKline (GSK) pleaded guilty in the US to withholding safety data from regulators, the global healthcare company has been proactive in restoring its image. But will a pledge to make detailed trial data available be eno…
Source: Pharmaceutical Technology - January 24, 2013 Category: Pharmaceuticals Source Type: news